Caspian Capital LP Bausch & Lomb Corp Transaction History
Caspian Capital LP
- $73.4 Million
- Q3 2024
A detailed history of Caspian Capital LP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Caspian Capital LP holds 650,000 shares of BLCO stock, worth $12.7 Million. This represents 17.09% of its overall portfolio holdings.
Number of Shares
650,000
Previous 475,000
36.84%
Holding current value
$12.7 Million
Previous $6.9 Million
81.79%
% of portfolio
17.09%
Previous 12.45%
Shares
5 transactions
Others Institutions Holding BLCO
# of Institutions
118Shares Held
37.8MCall Options Held
116KPut Options Held
299K-
Maple Rock Capital Partners Inc. Toronto, A63.62MShares$70.7 Million2.04% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$68.4 Million0.69% of portfolio
-
Goldentree Asset Management LP New York, NY3.36MShares$65.6 Million5.89% of portfolio
-
Alberta Investment Management Corp Edmonton, A02.21MShares$43.2 Million0.42% of portfolio
-
River Road Asset Management, LLC2.02MShares$39.5 Million0.54% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $6.84B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...